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DISCUSSION
Dr Steven Rivers (Bronx, NY): I have been intrigued and
impressed with the absence of spinal cord ischemia in the TEVAR
patients and in several other reports of similar endovascular treat-
ment of thoracic aneurysms. It makes me wonder if for the patients
that we still need to do open repairs on, are we wasting our time
doing intercostal reimplantations? Are we wasting our time with
spinal cord fluid measurements and various other procedures that
we have been doing to alleviate some of the problems with open
repair? But particularly, intuitively, we have always reimplanted as
many of these vessels as we can and, I mean, are we wasting our
time? And also, could you comment on whether or not there were
any specific protocols for your open repair techniques.
Dr Jon S. Matsumura: The incidence of paraplegia is not
zero with TEVAR. It does occur, and paraparesis with partial
weakness also occurs after TEVAR. However, it is my impression
that it is less frequent than in open repair. Nevertheless, we use
adjuncts per institutional protocol. In this trial, 26% of the TEVAR
patients had a spinal drain placed, and most institutions keep the
mean arterial pressure elevated.
With TEVAR, one cannot reimplant the intercostal vessels,
but one does have to decide on what to do when covering the left
subclavian artery, which provides the upper cord with some collat-
eral supply. Unlike a previous trial, we did not have a policy to
routinely revascularize the subclavian artery if it was covered in this
trial. In my own center, it is a routine practice to do it. Based on
EuroSTAR [European Collaborators on Stent/Graft Techniques
for Aortic Aneurysm Repair] data presented earlier, many centers
may begin to make that a routine practice. If subclavian revascu-
larization is helpful in TEVAR, that suggests that we are not
wasting our time with intercostal reimplantation with open repair.
The open repair techniques in this trial were also per institu-
tional protocol and not standardized, other than we excluded
planned deep hypothermic circulatory arrest. About 80% had
spinal cord protection, and that included epidural cooling, spinal
cord drainage, and distal perfusion in the majority of patients.
Dr Amy Reed (Cincinnati, Ohio): Could you share with us
just what you are doing for a preoperative evaluation of the carotids
and vertebrals. Are you just doing a carotid duplex or CT angiog-
raphy or anything specific to try and pick out those patients that
might have problems with stroke postoperatively?
Dr Matsumura: The reality is most TEVAR patients have a
CTA or MRA that images the aortic arch and most of the proximal
carotid and vertebral circulation. Inspecting the arch and carefully
selecting patients is probably important in preventing stroke with
TEVAR, similar to preventing stroke with transfemoral carotid
stenting. Based on my own experience, and that of some expert
colleagues in this room, if you are going to electively cover the left
subclavian with TEVAR, you should revascularize it. Our favorite
method is a transposition, unless they have an internal mammary
artery attached to a coronary artery, in which case we do a carotid–
subclavian bypass. If you do subclavian revascularization routinely,
there is not much benefit to image the distal vertebral or basilar
arteries.
If one practices selective revascularization, I strongly recom-
mend imaging both vertebral arteries and the intracranial circula-
tion. There will be a few patients with abnormalities that will
influence how the left vertebral or left subclavian are treated.
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